Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2026-01-01 @ 8:17 PM
Study NCT ID:
NCT01611558
Status:
COMPLETED
Last Update Posted:
2020-07-13
First Post:
2012-05-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Study of Ipilimumab Monotherapy in Recurrent Platinum-sensitive Ovarian Cancer
Sponsor:
Bristol-Myers Squibb
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Platinum-sensitive Ovarian Cancer, Second-line, Third-line, or Fourth-line | View |
Keywords: